Kalaris Therapeutics, Inc. (KLRS) stock
KLRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.37−0.06 (-4.20%)
Close on Nov 18, 2026Market cap $32.61MP/E –Yield –
Kalaris Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Kalaris Therapeutics's market cap was $45.23M on Nov 11, 2026, against $116.70M a year earlier. Over the last 5 years it ranged from $8.50M to $817.49M, with a median of $121.17M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $45.23M | -71.3% |
| 2025 | Dec 31, 2025 | $157.85M | +225.6% |
| 2024 | Dec 31, 2024 | $48.48M | -37.4% |
| 2023 | Dec 29, 2023 | $77.47M | -83.7% |
| 2022 | Dec 30, 2022 | $475.22M | -41.9% |
| 2021 | Dec 31, 2021 | $817.49M | -65.5% |
| 2020 | Dec 31, 2020 | $2.37B | – |
See a number that looks wrong?